ArticleCancer chemotherapy and pharmacology2021

Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1-NRF2 signaling.

Hui Zeng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.